Fresenius has successfully signed a €2 billion syndicated revolving credit facility with an international consortium of 29 core relationship banks. It has a maturity of five years with two one-year extension options and can be drawn in various currencies. 

The new credit facility replaces the existing €1.1 billion and US$500 million revolving credit facilities, originally entered into in 2012 and amended from time to time. It is intended to serve as a backup line for general corporate purposes. The increased volume will further strengthen Fresenius’ liquidity profile and increase the company’s financial flexibility. 

A key component of the new credit facility is the link to sustainability: Emphasizing Fresenius’ commitment to embed sustainability in all aspects of its business, the credit facility’s margin will be adjusted up or down according to changes in Fresenius’ sustainability performance. This is Fresenius’ first sustainability-linked financial transaction, demonstrating the increasing importance of sustainable financing.

Rachel Empey, Chief Financial Officer of Fresenius, said: “Sustainability is deeply rooted in our thinking and actions, at all levels. That is why it is important to us to take sustainability into account in our financing strategy. At the same time, with this credit facility we have increased our financial flexibility and further optimized our financing structure. In this way we are supporting investments in future growth and securing the company’s long-term success.”

Fresenius has successfully signed a €2 billion syndicated revolving credit facility with an international consortium of 29 core relationship banks. It has a maturity of five years with two one-year extension options and can be drawn in various currencies.

The new credit facility replaces the existing €1.1 billion and US$500 million revolving credit facilities, originally entered into in 2012 and amended from time to time. It is intended to serve as a backup line for general corporate purposes. The increased volume will further strengthen Fresenius’ liquidity profile and increase the company’s financial flexibility.

A key component of the new credit facility is the link to sustainability: Emphasizing Fresenius’ commitment to embed sustainability in all aspects of its business, the credit facility’s margin will be adjusted up or down according to changes in Fresenius’ sustainability performance. This is Fresenius’ first sustainability-linked financial transaction, demonstrating the increasing importance of sustainable financing.

Rachel Empey, Chief Financial Officer of Fresenius, said: “Sustainability is deeply rooted in our thinking and actions, at all levels. That is why it is important to us to take sustainability into account in our financing strategy. At the same time, with this credit facility we have increased our financial flexibility and further optimized our financing structure. In this way we are supporting investments in future growth and securing the company’s long-term success.”

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has successfully signed a new syndicated revolving credit facility with a group of 34 core relationship banks. It has a volume of EUR 2 billion with a term of five years plus two one-year extension options (“5+1+1” years) and can be drawn in different currencies. 

The new credit facility replaces the existing USD 900 million and EUR 600 million revolving credit facilities, initially signed in 2012 and amended from time to time, and will serve as a backup line for general corporate purposes. The increased volume will further strengthen Fresenius Medical Care’s liquidity profile and enhance the company’s financial flexibility.

Supporting the company’s commitment to create value in ecological, social and economic terms, a sustainability component has been embedded in the credit facility. Based on this structure, the credit facility’s margin will rise or fall depending on the company's sustainability performance. This is Fresenius Medical Care’s first sustainability-linked financing instrument.

Helen Giza, Chief Financial Officer of Fresenius Medical Care, said: “With the refinancing of the credit agreement we have further optimized our financing structure. The new facility improves Fresenius Medical Care’s liquidity profile and gives us greater financial flexibility for our long-term growth strategy. It also extends our focus on sustainability to our financing instruments. By linking the new credit agreement to our sustainability efforts, we are underlining our integrated approach to sustainability throughout all aspects of the business.”

Fresenius Medical Care has joined econsense, a network of German companies joined in the goal of shaping the transformation to a sustainable economy and society. The dialogue and cross-industry exchange of practical expertise within econsense, which now counts 40 major companies as members, will support Fresenius Medical Care’s sustainability management. Sustainability is an integral part of Fresenius Medical Care’s mission and vision and is also reflected in the corporate strategy. For the company, successful sustainability management means creating long-term economic, ecological and social value in order to provide patients with high-quality products and services while minimizing the impact of our activities on the environment.